Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Y Warren

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Clinical Radiology|July 11, 2019
Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathwaysT Barrett, R Slough, N Sushentsev, et al.
British Journal of Cancer|July 25, 2013
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stressH C Whitaker, D Patel, W J Howat, et al.
Oncogene|November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotypeH C Whitaker, L L Shiong, J D Kay, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
Ebiomedicine|October 27, 2015
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studyH Ross-Adams, A D Lamb, M J Dunning, et al.
Ebiomedicine|March 16, 2017
Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]H Ross-Adams, A D Lamb, M J Dunning, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Clinical Radiology|July 11, 2019
Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathwaysT Barrett, R Slough, N Sushentsev, et al.
British Journal of Cancer|July 25, 2013
Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stressH C Whitaker, D Patel, W J Howat, et al.
Oncogene|November 19, 2013
N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotypeH C Whitaker, L L Shiong, J D Kay, et al.
British Journal of Cancer|August 25, 2011
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT studyJ W F Catto, M C Robinson, P C Albertsen, et al.
Ebiomedicine|October 27, 2015
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studyH Ross-Adams, A D Lamb, M J Dunning, et al.
Ebiomedicine|March 16, 2017
Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]H Ross-Adams, A D Lamb, M J Dunning, et al.
Pageof 4